#1 Cancer Vaccines

Overview

These targeted therapies are being used to prevent cancer and treat patients more specifically according to the type of cancer they have. One example of a cancer vaccine is the HPV vaccine developed to prevent cervical cancer caused by human papillomaviruses. This has been a clinical and commercial success, with sales over $1 billion for 2007-2008. This cervical cancer vaccine is now widely used, with 25% of American teenage girls vaccinated in 2007.

These targeted therapies are being used to prevent cancer and treat patients more specifically according to the type of cancer they have. One example of a cancer vaccine is the HPV vaccine developed to prevent cervical cancer caused by human papilloma viruses. Approximately 25% of American teenage girls were vaccinated with the HPV vaccine in 2007.

Where Are They Now

These targeted therapies are being used to prevent cancer and treat patients more specifically according to the type of cancer they have. One example of a cancer vaccine is the HPV vaccine developed to prevent cervical cancer caused by human papilloma viruses. Approximately 25% of American teenage girls were vaccinated with the HPV vaccine in 2007. Currently, researchers are working on developing therapeutic vaccines for a variety of cancers including breast, lung, colon, skin, kidney, and prostate.

The FDA approved the first therapeutic vaccine for advanced prostate cancer in 2010, and there are more than 270 therapeutic vaccine candidates currently in the pipeline. Personalized cancer vaccines, vaccines tailored to the unique genetic makeup of an individuals’ tumor, have shown promising results in two new studies. Personalized cancer vaccine approaches have safely and efficiently prevented relapse in nearly a dozen patients with late-stage skin cancer. Many vaccines are expected to gain FDA approval soon, for indications such as lung and colorectal cancer, and would boost the global cancer vaccine market to be worth $7.8 billion by 2019.

Get In Touch With Us